MacroGenics, Inc. (MGNX)
3.74
+0.19
(+5.35%)
USD |
NASDAQ |
Oct 09, 16:00
3.74
0.00 (0.00%)
After-Hours: 20:00
MacroGenics EPS Diluted (Quarterly) : 0.3069 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3069 |
| March 31, 2026 | -0.5796 |
| December 31, 2025 | -0.2236 |
| September 30, 2025 | 0.2658 |
| June 30, 2025 | -0.5742 |
| March 31, 2025 | -0.6517 |
| December 31, 2024 | -0.2463 |
| September 30, 2024 | 0.8974 |
| June 30, 2024 | -0.8883 |
| March 31, 2024 | -0.8378 |
| December 31, 2023 | -0.7422 |
| September 30, 2023 | 0.282 |
| June 30, 2023 | 0.923 |
| March 31, 2023 | -0.6149 |
| December 31, 2022 | 0.2075 |
| September 30, 2022 | -0.4037 |
| June 30, 2022 | -0.6729 |
| March 31, 2022 | -1.084 |
| December 31, 2021 | -0.9464 |
| September 30, 2021 | -0.8646 |
| June 30, 2021 | -0.6648 |
| March 31, 2021 | -0.8963 |
| December 31, 2020 | -0.0371 |
| September 30, 2020 | -0.6618 |
| June 30, 2020 | -0.9374 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.9125 |
| December 31, 2019 | -0.6208 |
| September 30, 2019 | -0.9126 |
| June 30, 2019 | -0.6504 |
| March 31, 2019 | -0.9871 |
| December 31, 2018 | -1.055 |
| September 30, 2018 | -0.8056 |
| June 30, 2018 | -1.03 |
| March 31, 2018 | -1.341 |
| December 31, 2017 | 2.80 |
| September 30, 2017 | -1.28 |
| June 30, 2017 | -1.14 |
| March 31, 2017 | -1.08 |
| December 31, 2016 | -1.00 |
| September 30, 2016 | -0.97 |
| June 30, 2016 | 1.12 |
| March 31, 2016 | -0.88 |
| December 31, 2015 | -0.83 |
| September 30, 2015 | -0.46 |
| June 30, 2015 | -0.71 |
| March 31, 2015 | 1.42 |
| December 31, 2014 | -0.68 |
| September 30, 2014 | -0.14 |
| June 30, 2014 | -0.44 |
| March 31, 2014 | -0.12 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | -8.444 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -69.64M |
| Revenue (Quarterly) | 32.83M |
| Total Expenses (Quarterly) | 102.47M |
| Enterprise Value | 262.98M |
| Gross Profit Margin (Quarterly) | 97.84% |
| Profit Margin (Quarterly) | -212.1% |
| Earnings Yield | -6.16% |
| Normalized Earnings Yield | -6.160 |